Short form equity change report
Name of listed company: Daan Gene Co.Ltd(002030) place of stock listing: Shenzhen Stock Exchange
Stock abbreviation: Daan Gene Co.Ltd(002030)
Stock Code: 002030
Information disclosure obligor: Guangzhou bioengineering Center Co., Ltd
Address: Room 301, No. 34, Longkou East Road, Tianhe District, Guangzhou
Mailing address: Room 301, No. 34, Longkou East Road, Tianhe District, Guangzhou
Nature of equity change: decrease in the number and proportion of shares held
February, 2002
Statement of information disclosure obligor
1、 This report is prepared by the information disclosure obligor in accordance with the company law of the people's Republic of China, the securities law of the people's Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the content and format of information disclosure by public securities companies No. 15 - Report on changes in equity and other relevant laws, regulations and normative documents.
2、 The information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with any provision in the articles of association or internal rules of the information disclosure obligor.
3、 In accordance with the securities law of the people's Republic of China and the measures for the administration of the acquisition of listed companies, this report has fully disclosed the changes in the shares in which the information disclosure obligor has interests in Daan Gene Co.Ltd(002030) ;
As of the signing date of this report, except for the information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Daan Gene Co.Ltd(002030) by any other means. 4、 This equity change is based on the information stated in this report. The information disclosure obligor has not entrusted or authorized any other person to provide information not listed in this report and make any explanation or explanation to this report.
5、 The information disclosure obligor promises that there are no false records, misleading statements or major omissions in this report, and will bear individual and joint legal liabilities for its authenticity, accuracy and completeness.
catalogue
The disclosure obligor declares that 1 interpretation Section 1 Introduction to information disclosure obligors 4 Section 2 purpose of equity change Section III equity change method Section IV trading of shares of Listed Companies in the first six months Section V other major matters Section VI documents for future reference 12 the disclosure obligor declares that 13 attached table brief report on changes in equity - Daan Gene Co.Ltd(002030) fifteen
interpretation
In this report, unless otherwise specified, the following abbreviations have the following specific meanings: This report / equity change report refers to the information disclosure obligor of Daan Gene Co.Ltd(002030) simplified equity change report and bioengineering
Guangzhou bioengineering Center Co., Ltd
Center and transferor
Daan Gene Co.Ltd(002030) . Listed company refers to Daan Gene Co.Ltd(002030)
Guangzhou financial holding group and the transferee refer to Guangzhou Financial Holding Group Co., Ltd., the parent company of the information disclosure obligor
The transfer of the wholly-owned interests of the group's biological engineering center to the wholly-owned subsidiaries of the group
Daan Gene Co.Ltd(002030) 5% shares are transferred to their direct holding free of charge
China Securities Regulatory Commission
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
Special note: the data listed in this report may be slightly different from the sum directly added according to the relevant single data due to rounding.
Section I Introduction to information disclosure obligors
1、 Basic information of information disclosure obligor
Company name: Guangzhou bioengineering Center Co., Ltd
Registered address: Room 301, No. 34, Longkou East Road, Tianhe District, Guangzhou
Legal representative: Xue zheqiang
Unified social credit code 91440101ma5d1rgk27
Company type: limited liability company (sole proprietorship of legal person)
The registered capital is 10 million yuan
Date of establishment: November 18, 2019
Business term: November 18, 2019 to no fixed term
Scientific and technological achievements appraisal service; Science and technology project evaluation services; Technology project agency services; Scientific and technological information consulting services; Biotechnology development services; Biotechnology consultation, exchange and business scope services; Biotechnology transfer services; Biotechnology extension services; Medical research and experimental development; Data processing and storage services; Conference and exhibition services; Human resource management consulting; Provide information consulting services for overseas students on entrepreneurship and investment projects; House leasing; Self owned real estate business activities; Enterprise's own capital investment
Shareholder name and shareholding ratio Guangzhou financial holding group holds 100%
Mailing address: Room 301, No. 34, Longkou East Road, Tianhe District, Guangzhou
Postal Code: 510635
Tel: 020-87568623-313
2、 Information about the directors and main responsible persons of the information disclosure obligor
As of the signing date of this report, the basic information of the directors and main principals of the information disclosure obligor is as follows:
Name position gender Nationality Date of birth permanent residence right of residence in other countries or regions
Xue zheqiang, chairman, male, China, Guangzhou, April 1988
Huang Liqiang, director, male, China, November 1967, Guangzhou no
Zeng Jun, director, male, China, August 1995, Guangzhou no
Cheng Guanping, director, male, China, September 1978, Guangzhou no
3、 Information disclosure obligors holding and controlling other listed companies
As of the date of signing this report, the information disclosure obligor does not have shares with interests in other domestic and foreign listed companies that reach or exceed 5% of the issued shares.
Section 2 purpose of equity change
1、 Purpose of this equity change
This equity change is a free transfer of state-owned assets by Guangzhou financial holding group, the parent company of the information disclosure obligor, in order to promote the integration of relevant state-owned assets, improve the liquidity of state-owned assets and promote the maintenance and appreciation of state-owned assets. 2、 Shareholding plan of information disclosure obligor in the next 12 months
As of the signing date of this report, the information disclosure obligor has no clear plan to continue to increase the shares of the listed company or dispose of the shares in which it has interests in the next 12 months.
In the next 12 months, if the information disclosure obligor makes a decision to increase or dispose of the shares of the listed company, it will perform the information disclosure obligation in strict accordance with the securities law of the people's Republic of China, the measures for the administration of the acquisition of listed companies and other relevant laws and regulations.
Section III changes in equity
1、 Method of this equity change
Prior to this equity change, the information disclosure obligor held Daan Gene Co.Ltd(002030) 210516909 shares, all of which were A-Shares of unlimited sale and circulation, accounting for 15.00% of the total share capital of Daan Gene Co.Ltd(002030) .
The way of equity change is free transfer of state-owned equity, and Daan Gene Co.Ltd(002030) 70172302 shares directly held by the information disclosure obligor (accounting for 5% of the total share capital of Daan Gene Co.Ltd(002030) ) are transferred to Guangzhou financial holding group for free.
After this equity change, the information disclosure obligor will hold Daan Gene Co.Ltd(002030) 140344607 shares, all of which are non tradable A shares, accounting for 10.00% of the total share capital of Daan Gene Co.Ltd(002030) , and will still be the second largest shareholder of the listed company. The details are as follows:
Unit: shares;%
Before and after transfer
Direct shareholding indirect shareholding
name
Number of shares ratio of shares to number of shares ratio of shares to number of shares ratio of shares to number of shares
biology
Project 210516909 15.00 -- 140344607 10.00 --
Central Guangzhou
Financial holding - 443908904 31.63 70172302 5.00 373736602 26.63 group
remarks:
1. Indirect shareholding of Guangzhou financial holding group includes its indirect holding of Daan Gene Co.Ltd(002030) shares through its wholly-owned subsidiaries Guangzhou Zhongda Holding Co., Ltd. and Guangzhou bioengineering Center Co., Ltd;
2. The Daan Gene Co.Ltd(002030) shares held by Guangzhou bioengineering Center Co., Ltd. include the shares lent by refinancing securities lending business. 2、 Authorization and approval of the implementation of this equity change
As of the signing date of this report, the main decision-making and approval procedures for this equity change are as follows: on January 10, 2022, Guangzhou financial holding group held a board meeting to consider and approve the transfer of Daan Gene Co.Ltd(002030) 5% shares held by bioengineering center to Guangzhou financial holding group.
On January 14, 2022, Guangzhou financial holding group issued the notice of Guangzhou financial holding group on matters related to the free transfer of Daan Gene Co.Ltd(002030) 5% state-owned shares held by Guangzhou bioengineering Center Co., Ltd. (Guangzhou financial holding [2022] No. 9) to the bioengineering center.
On January 17, 2022, the bioengineering Center convened the board of directors to consider and approve the transfer of Daan Gene Co.Ltd(002030) 5% shares held by the bioengineering center to Guangzhou financial holding group.
On February 7, 2022, Guangzhou financial holding group and bioengineering Center signed the agreement on free transfer of state-owned shares. 3、 Main contents of agreements related to this equity change
As of the signing date of this report, the transferor Guangzhou financial holding group and the transferor bioengineering center have signed the free transfer agreement of state-owned shares, the main contents of which are as follows:
(I) signatory
Transferee (Party A): Guangzhou Financial Holding Group Co., Ltd
Transferor (Party B): Guangzhou bioengineering Center Co., Ltd
(II) transfer of shares
1. The subject shares transferred free of charge this time are 5% of the shares of the subject company held by Party B (corresponding to 70172302 shares). If the number of shares held by Party B in the target company increases due to dividend distribution, share distribution, share allotment, capital reserve conversion to share capital and other matters of the target company after the signing of this Agreement and before the completion of share transfer registration procedures, the number of transferred shares shall be calculated according to 5% of the latest total share capital of the target company after the implementation of the above matters. 2. The subject shares are all tradable shares, accounting for 33.33% of the shares of the subject company held by Party B.
3. The nature of the underlying shares is state-owned legal person shares. After the free transfer is completed, the nature of the underlying shares will not change.
(III) transfer base date
1. Party A and Party B confirm that the benchmark date of this free transfer is December 31, 2021.
2. Upon the completion of this transfer, the profits and losses of the subject shares recognized before the base date shall be enjoyed by Party B, and the profits and losses of the subject shares recognized after the base date (including but not limited to the dividends and bonuses distributed by the subject company) shall be enjoyed by Party A.
(IV) share transfer price and expenses
1. This share transfer is free, and Party A does not need to pay any price. Party A shall take December 31, 2021 as the base date and conduct accounting treatment according to the audit report issued by an accounting firm with securities qualification.
2. All taxes arising from the free transfer of the subject shares shall be borne by Party A and Party B in accordance with the provisions of laws and regulations.
(V) effective conditions
This Agreement shall come into force after the legal representatives of both parties sign and affix their official seals, and the free transfer of shares is officially approved by Party A. 4、 Is there any restriction on the rights of the shares subject to this equity change
As of the signing date of this report, the listed assets held by the information disclosure obligor involved in this equity change
